HWA
DNA.WS

HHM Wealth Advisors’s Ginkgo Bioworks Holdings, Inc. Warrants, each whole warrant exercisable to purchase one-fortieth (1/40th) of a share of Class A Common Stock at an exercise price of $460.00 per share DNA.WS Stock Holding History

HHM Wealth Advisors’s Portfolio DNA.WS Stock Details DNA.WS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-100
Closed -$3 – 840
2024
Q2 		$3 Hold
100
– – ﹤0.01% 785
2024
Q1 		$9 Hold
100
– – ﹤0.01% 738
2023
Q4 		$11 Hold
100
– – ﹤0.01% 740
2023
Q3 		$23 Hold
100
– – ﹤0.01% 780
2023
Q2 		$27 Hold
100
– – ﹤0.01% 797
2023
Q1 		$18 Hold
100
– – ﹤0.01% 811
2022
Q4 		$20 Hold
100
– – ﹤0.01% 687
2022
Q3 		$0 Hold
100
– – ﹤0.01% 836
2022
Q2 		$0 Hold
100
– – ﹤0.01% 855
2022
Q1 		$0 Hold
100
– – ﹤0.01% 763
2021
Q4 		$0 Hold
100
– – ﹤0.01% 710
2021
Q3 		$0 Buy
+100
New +$356 ﹤0.01% 670

Other funds holding DNA.WS

AS
Altshuler Shaham Tel Aviv, Israel $5.54B AUM 44.68% 1-Year Est. Return
SBLIC
Security Benefit Life Insurance Company Topeka, Kansas $182M AUM 31.21% 1-Year Est. Return
HIA
Harbor Investment Advisory Lutherville, Maryland $1.43B AUM 30.71% 1-Year Est. Return
SPIA
Steward Partners Investment Advisory New York $19.6B AUM 22.89% 1-Year Est. Return

HHM Wealth Advisors's DNA.WS Position: Q3 2024 in Review

HHM Wealth Advisors sold out of Ginkgo Bioworks Holdings, Inc. Warrants, each whole warrant exercisable to purchase one-fortieth (1/40th) of a share of Class A Common Stock at an exercise price of $460.00 per share (DNA.WS) in Q3 2024, closing a stake of 100 shares — an estimated $3 sold.

HHM Wealth Advisors first reported a position in DNA.WS in Q3 2021 and held it in 12 quarters. The position peaked at $27 in Q2 2023. 5 funds tracked by Wall St. Rank hold DNA.WS as of Q3 2024.

  • HHM Wealth Advisors reported no remaining Ginkgo Bioworks Holdings, Inc. Warrants, each whole warrant exercisable to purchase one-fortieth (1/40th) of a share of Class A Common Stock at an exercise price of $460.00 per share position as of Q3 2024 after selling out during the quarter.
  • HHM Wealth Advisors sold 100 Ginkgo Bioworks Holdings, Inc. Warrants, each whole warrant exercisable to purchase one-fortieth (1/40th) of a share of Class A Common Stock at an exercise price of $460.00 per share shares in Q3 2024, an estimated $3.
  • HHM Wealth Advisors first reported a position in Ginkgo Bioworks Holdings, Inc. Warrants, each whole warrant exercisable to purchase one-fortieth (1/40th) of a share of Class A Common Stock at an exercise price of $460.00 per share in Q3 2021 and held it in 12 quarters.
  • HHM Wealth Advisors's Ginkgo Bioworks Holdings, Inc. Warrants, each whole warrant exercisable to purchase one-fortieth (1/40th) of a share of Class A Common Stock at an exercise price of $460.00 per share position peaked at $27 in Q2 2023.
  • 5 funds tracked by Wall St. Rank held Ginkgo Bioworks Holdings, Inc. Warrants, each whole warrant exercisable to purchase one-fortieth (1/40th) of a share of Class A Common Stock at an exercise price of $460.00 per share as of Q3 2024.

Based on HHM Wealth Advisors's 13F filing for Q3 2024, filed 12 Nov 2024.